Drug Test Cups with Fentanyl & Alcohol |
Rapid Urine Screening Tests

Drug Test Cups with Fentanyl and Alcohol Detection

Urine drug test cups with fentanyl and alcohol (ETG) that simultaneously screen for Fentanyl (FEN) at 20 ng/mL and Ethyl Glucuronide (ETG) for up to 80-hour alcohol detection alongside complete standard substance baselines, available from $1.09 per cup in configurations from 6-panel through 18-panel. Every cup in this collection combines the post-July 2025 HHS-authorized FEN strip with the ETG alcohol metabolite strip in a single sealed device with a built-in temperature strip and no-drip click-top lid, eliminating the need for separate fentanyl strips and breathalyzer or ALC tests at each monitoring appointment. Searching for drug test cups with fentanyl and alcohol near me? 12 Panel Now ships same-day wholesale before 3:00 PM EST anywhere in the US with free shipping on qualifying bulk orders. As the manufacturer of the Serenity brand drug testing product line, 12 Panel Now produces all FEN+ETG drug test cups to the same quality standards applied across the full product range.

What Are Drug Test Cups That Test for Both Fentanyl and Alcohol?

Drug test cups with fentanyl and alcohol detection are urine collection devices that integrate a dedicated FEN (Fentanyl) immunoassay strip at 20 ng/mL and an ETG (Ethyl Glucuronide) strip at 300 ng/mL alongside the standard multi-substance baseline, allowing a single sealed cup to simultaneously screen for fentanyl exposure and alcohol consumption up to 80 hours after the last drink without requiring separate test devices for either substance. At 12 Panel Now, the drug test cups with fentanyl and alcohol collection covers configurations from the 6-panel specialty format (SM-CDOA-165F-FUO-90, from $1.09) through the 18-panel comprehensive format (SM-CDOA-9185FUO, from $2.09), with every product in the collection sharing two defining features: FEN at 20 ng/mL in compliance with the HHS Federal Register mandate effective July 7, 2025, and ETG at 300 ng/mL providing the extended retrospective alcohol detection that a standard ALC (blood ethanol) strip cannot achieve. The SAMHSA Drug-Free Workplace Program classifies both FEN and ETG as requiring dedicated immunoassay strips separate from any standard drug class analyte. Neither is detected by the standard OPI, BZO, AMP, or THC strips on a conventional multi-panel cup. As the manufacturer of the Serenity brand drug testing product line, 12 Panel Now produces all FEN+ETG cups to the same quality standards applied across the full product range.

Does a Standard Drug Test Cup Test for Alcohol?

Also known as: drug test cup with alcohol detection | ETG cup | alcohol urine test cup

A standard drug test cup with alcohol detection requires a dedicated ETG strip — without one, a standard drug test cup does not test for alcohol. The standard multi-panel cup configurations covering AMP, BZO, COC, MET, MTD, OPI, OXY, BUP, MDMA, PCP, and THC contain no immunoassay strips capable of detecting ethanol or its metabolites. Alcohol produces no cross-reactivity on any of these standard drug class strips. Only a urine drug test cup with ETG integrated — or a separate ALC strip — detects alcohol consumption, and the ETG format is preferred in compliance and clinical settings because it detects alcohol up to 80 hours after the last drink rather than the 6 to 12 hour window of standard ethanol detection. Every cup in the 12 Panel Now FEN+ETG collection answers the question “does a drug test cup test for alcohol” with a confirmed yes: all products in this collection include a dedicated ETG strip at 300 ng/mL calibrated to the SAMHSA-recommended retrospective alcohol monitoring threshold.

Why Do Compliance Programs Need Both Fentanyl and Alcohol Detection in the Same Cup?

Probation programs, drug courts, sober living homes, employer programs, and addiction treatment centers that have both fentanyl abstinence and alcohol abstinence as conditions of supervision or treatment cannot meet both requirements in a single test without a cup that integrates FEN and ETG simultaneously, making the FEN+ETG cup format the minimum compliant device for programs needing drug test cups fentanyl and alcohol coverage in a single sealed unit. The operational case for the combined cup format is straightforward: running a standard multi-panel cup for drugs alongside a separate breathalyzer or ALC strip for alcohol creates two separate testing events, two separate result documentation entries, two separate quality control steps, and double the consumable cost per collection. A FEN+ETG cup replaces all of that with a single sealed device, a single dip, a single 5-minute wait, and a single result window read. For probation programs where participants have both fentanyl-related criminal history and alcohol-related conditions, the 12 or 14 panel FEN+ETG cup is the standard format. For sober living homes with total abstinence policies covering both substances, the 12 panel ETG+FEN economy cup at $1.69 provides complete coverage at a price point appropriate for daily high-frequency monitoring. For drug courts operating evidence-based monitoring protocols, the 14 panel ETG+FEN cup adds PCP and the full extended substance baseline alongside the two primary compliance markers. The National Association of Drug Court Professionals standards recognize both substance and alcohol monitoring as components of evidence-based drug court protocols, and the FEN+ETG cup format addresses both within a single tested specimen.

Which Programs Benefit Most from Combining Fentanyl and Alcohol in One Cup?

Programs where participants have co-occurring alcohol use disorder and opioid use disorder are the primary buyers for FEN+ETG cups. According to the SAMHSA 2024 National Survey on Drug Use and Health, co-occurring substance and alcohol use disorders are documented in the majority of individuals engaged in formal addiction treatment. Residential treatment programs use the 14 panel ETG+FEN cup as their standard monitoring format because it closes both the fentanyl detection gap and the alcohol detection gap in a single device. Employers in transportation, construction, and healthcare where both fentanyl impairment and alcohol impairment are safety concerns use the 12 panel ETG+FEN cup for post-incident and reasonable-suspicion testing. Methadone clinics and buprenorphine programs use the 14 or 16 panel ETG+FEN format because their patients’ histories frequently include alcohol alongside opioids.

Does an ETG Drug Test Detect the Same Thing as a Breathalyzer?

No, a breathalyzer vs ETG drug test comparison reveals they detect entirely different things: a breathalyzer measures the concentration of ethanol vapor in exhaled breath as a proxy for blood alcohol concentration at the moment of testing, while an ETG drug test cup detects Ethyl Glucuronide in urine, a metabolite produced by the liver when it processes ethanol, which persists in urine for the full ETG 80 hours window after all the ethanol itself has been eliminated from the blood and breath. This is the most clinically significant distinction between the two methods. A breathalyzer reading of 0.00 at 10 hours after the last drink is an accurate measure of current blood ethanol: the ethanol is genuinely gone. But that person’s urine may still contain detectable ETG for another 60 to 70 hours. For probation programs and drug courts with alcohol abstinence conditions that test on weekly or semi-weekly schedules, a breathalyzer is functionally useless as a compliance monitoring tool because any alcohol consumed between appointments will have cleared long before the next test. An ETG cup at 300 ng/mL extends the detection window to 80 hours, covering the full inter-appointment interval in weekly monitoring programs. The NIH research on ethyl glucuronide as an alcohol biomarker confirms that ETG’s detection window represents a fundamental improvement over direct ethanol measurement for retrospective compliance monitoring, and the SAMHSA Mandatory Guidelines specifically recommend ETG as the preferred biomarker for extended alcohol monitoring in compliance settings.

How Long After Drinking Does an ETG Drug Test Cup Detect Alcohol?

How long after drinking does ETG detect alcohol? A urine drug test cup with ETG at 300 ng/mL detects alcohol consumption for up to 80 hours after the last drink in most adults consuming moderate to heavy amounts of alcohol. Actual detection windows vary by consumption amount, individual metabolic rate, kidney function, and body weight. Light social drinking of one to two standard drinks typically produces detectable ETG concentrations for 24 to 48 hours. Moderate drinking of three to five drinks may produce detectable concentrations for 48 to 72 hours. Heavy drinking of six or more drinks may produce concentrations detectable to the 80-hour window. Importantly, the ETG strip does not distinguish between these scenarios: any positive ETG result indicates alcohol consumption within the preceding 24 to 80 hours, and the test result alone does not quantify how much was consumed or when. All presumptive positive results must be confirmed by GC-MS or LC-MS/MS laboratory testing before any consequential action is taken.

Does a Drug Test Cup That Tests for Fentanyl Also Detect Other Opioids?

Yes, every drug test cup in this collection includes a standard OPI (Opiate/Morphine) strip at 300 ng/mL in addition to the dedicated FEN (Fentanyl) strip at 20 ng/mL, meaning the cup simultaneously screens for both the fentanyl synthetic opioid and the classical opiate/morphine class in a single test, but the two strips detect different substances and one cannot substitute for the other. The OPI strip fentanyl cross-reactivity is insufficient for detection: the OPI strip detects morphine, codeine, heroin (as 6-MAM/morphine metabolites), and related classical opioid compounds, but does not detect fentanyl at clinically encountered concentrations. The FEN strip at 20 ng/mL uses fentanyl-specific antibodies. A person using fentanyl but not morphine or heroin will show FEN-positive and OPI-negative on the same cup, a pattern completely invisible on any cup that includes only an OPI strip without a dedicated FEN strip. The 12 panel ETG+FEN economy cups at $1.69 provide this dual opioid class coverage at the lowest price point in this collection. The Quest Diagnostics 2025 Drug Testing Index documents fentanyl positivity at 1.13% in random workforce testing with 60% of fentanyl-positive specimens co-positive for another substance, reinforcing the value of the OPI+FEN dual coverage these cups provide.

Does an ETG or Fentanyl Cup Also Test for Oxycodone and Buprenorphine?

Every 12-panel and higher fentanyl urine test cup in the FEN+ETG range includes a dedicated OXY (Oxycodone) strip at 100 ng/mL and a BUP (Buprenorphine) strip at 10 ng/mL alongside the FEN and ETG strips, providing simultaneous coverage for oxycodone, buprenorphine, fentanyl, and alcohol metabolite in a single cup. Oxycodone does not produce adequate cross-reactivity on the standard OPI strip at 300 ng/mL, which is why the OXY strip is a separate dedicated analyte. Buprenorphine does not cross-react with the OPI strip either, requiring its own dedicated BUP strip at 10 ng/mL, which is the most sensitive analyte in the collection. For buprenorphine programs that need to simultaneously confirm BUP compliance and screen for illicit fentanyl alongside alcohol monitoring, the 14 panel ETG+FEN cup at $1.79 provides all three in a single sealed device. This combination is particularly valuable for pain management clinics and MAT programs whose patients are prescribed buprenorphine or oxycodone and need monitoring for both prescription compliance and illicit substance use simultaneously.

What Is the Difference Between the 12 Panel ETG FEN Cup and the 14 Panel ETG FEN Cup?

The 12 panel drug test cup with fentanyl and alcohol (ETG) covers twelve substances including AMP, BUP, BZO, COC, ETG, FEN, MET, MTD, OPI, OXY, PCP, and THC, while the 14 panel drug test cup ETG and fentanyl adds BAR (Barbiturates) and MDMA (Ecstasy) to the same baseline, making the 14-panel the more comprehensive clinical screening option for programs that need the extended substance coverage alongside FEN and ETG at a minimal price premium of $0.10 per test. The 12 panel ETG+FEN economy 90mL cup (SM-CDOA-9125-90) at $1.69 is the lowest-cost entry point for FEN+ETG dual detection. The 14 panel ETG+FEN 90mL cup (SM-CDOA-7145-90) at $1.79 adds BAR and MDMA for settings that have documented barbiturate or ecstasy use in their supervised population. For programs that additionally need Tramadol (TRA) detection, the 14 panel ETG+FEN+TRA cup (SM-CDOA-8145FUO) extends the analyte set to cover the opioid-adjacent analgesic invisible to standard OPI strips, as documented at the 13-panel dip card page. For programs needing adulterant validity checking alongside the specialty strips, the 14 panel ETG+FEN+TRA+K2+ADLTX 90mL cup (SM-CDOA-8145EFKTAD3-FUO-90) at $1.99 includes Specific Gravity, pH, and Creatinine validity strips running simultaneously with the drug panel.

Which FEN+ETG Cup Configuration Is Right for Your Program?

Programs whose primary monitoring need is fentanyl abstinence plus alcohol abstinence on the standard twelve-substance baseline should select the 12 panel ETG+FEN economy cup at $1.69 for cost-efficient high-frequency monitoring. Programs that have identified barbiturate or ecstasy use in their supervised population should upgrade to the 14 panel ETG+FEN at $1.79 for broader baseline coverage. Programs managing populations with documented tramadol use should select the 14 panel ETG+FEN+TRA cup at $2.79 or the 14 panel ETG+FEN+TRA+K2+ADLTX at $1.99 if specimen validity checking is also required. Programs managing comprehensive polydrug risk including ketamine should evaluate the 18 panel ETG+FEN+KET+TRA cup at $2.09. Contact the 12 Panel Now clinical team at 561-897-9238 or [email protected] for a customized recommendation.

Who Uses Drug Test Cups with Fentanyl and Alcohol Detection?

Drug test cups with fentanyl and alcohol detection are used by probation programs with dual substance and alcohol supervision conditions, drug courts conducting evidence-based monitoring, sober living homes with total abstinence policies, residential and outpatient addiction treatment programs managing co-occurring substance and alcohol use disorders, MAT programs monitoring patients whose treatment histories include alcohol use disorder alongside opioid use disorder, employers in safety-sensitive industries, and occupational medicine clinics conducting post-incident testing. Probation programs are the largest single buyer category for the 12 and 14 panel ETG+FEN cups because probation conditions covering both drug abstinence and alcohol abstinence are standard in opioid-related criminal cases. Residential treatment centers use the 14 panel ETG+FEN cup as their standard monitoring format because co-occurring alcohol and opioid use disorder is documented in the majority of their patient populations. Employer drug testing programs in construction, transportation, and logistics use the 12 panel ETG+FEN cup for post-incident testing where simultaneous fentanyl and alcohol documentation in a single sealed device supports the legal defensibility of the test result.

Is the FEN+ETG Drug Test Cup Right for DOT-Regulated Employer Testing?

For DOT-regulated employers, the federal 5-panel requirement does not include FEN or ETG, and DOT testing must use specific DOT-approved procedures separate from the cups in this collection. However, DOT-regulated employers may use FEN+ETG cups for supplemental non-safety-sensitive employee testing outside the federally regulated program. For non-DOT employers in any industry, the FEN+ETG cup is the appropriate upgrade from a standard 12-panel when fentanyl exposure has been identified as a workforce risk following the post-July 2025 HHS fentanyl authorization, and when alcohol abstinence monitoring is an employment condition. The OSHA Drug-Free Workplace guidelines confirm that non-regulated employers may configure their panels to reflect the specific substance risk profile of their workforce.

Buying Drug Test Cups with Fentanyl and Alcohol in Bulk

At 12 Panel Now, drug test cups with fentanyl and alcohol bulk and fentanyl alcohol drug test cup wholesale pricing starts from $1.09 per cup for the 6-panel specialty format and from $1.69 for the 12 panel ETG+FEN economy format, with same-day shipping before 3:00 PM EST and free shipping on orders of 100 cups or more. As the US-based manufacturer of the Serenity brand drug testing product line, 12 Panel Now maintains over 8 million drug test cups in stock at all times with no backorders across all FEN+ETG configurations. Each cup is individually sealed with an 18 to 24 month shelf life. Store between 36 and 86 degrees Fahrenheit away from direct sunlight and humidity. The BUP strip at 10 ng/mL and the FEN strip at 20 ng/mL are the most analytically sensitive strips across this collection and benefit most from temperature-controlled bulk storage for large volume orders. Send a competitor rate sheet and 12 Panel Now beats it by 10% guaranteed. OEM, private label, and custom configurations are available for qualified accounts. Contact the wholesale team at 561-897-9238 or [email protected].

Drug Test Cups with Fentanyl and Alcohol at 12 Panel Now (Serenity Drug Test / Slash Medical), 801 N Congress Ave, Boynton Beach FL 33426. Manufacturer of the Serenity brand drug testing product line. All cups include ETG/300 and FEN/20 as integrated strips. Key products: SM-CDOA-165F-FUO-90 (6-panel FEN+KRA+ETG+XYL+K2, from $1.09); SM-CDOA-9125-90 (12-panel ETG+FEN economy, from $1.69); SM-CDOA-7145-90 (14-panel ETG+FEN economy, from $1.79); SM-CDOA-7145FUO (14-panel ETG+FEN 120mL, from $1.79); SM-CDOA-8145FUO (14-panel ETG+FEN+TRA, from $2.79); SM-CDOA-8145EFKTAD3-FUO-90 (14-panel ETG+FEN+TRA+K2+ADLTX, from $1.99); SM-CDOA-9185FUO (18-panel ETG+FEN+KET+TRA, from $2.09). Regulatory references: HHS fentanyl authorization effective July 7, 2025. SAMHSA Mandatory Guidelines 2025. NIH ethyl glucuronide alcohol biomarker research. Quest Diagnostics 2025 Drug Testing Index. NADCP drug court monitoring standards. OSHA Drug-Free Workplace guidelines. SAMHSA 2024 National Survey on Drug Use and Health.